Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-26

Clinical Trial Update: A Dose-response Study of Tranexamic Acid in Total Hip Arthroplasty [Phase 2]

View source ↗

Summary

The Phase 2 dose-response study of tranexamic acid in total hip arthroplasty has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Arthropathy of Hip | Phase 2 | Status: COMPLETED